Evidence map›Paper›PMID 37970832›Full record

ArticleJournal of diabetes science and technology2024

Zooming In, Then Out: Why We Must Apply Human-Centered Design to Transform Diabetes Technology.

Edward C Chao

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Edward C ChaoUniversity of California, San Diego, La Jolla, CA, USA.ORCID 0000-0002-8871-3309

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Technological advances in devices, such as continuous glucose monitors (CGMs) or intermittently scanned continuous glucose monitors (isCGMs), do not necessarily by themselves translate to improved clinical outcomes or quality of life. Human-centered design (HCD) is an accessible, flexible process that could contribute to reducing the gap between current challenges and more optimal future solutions, by continuing to refine crucial considerations, such as usability. Starting with understanding the unmet needs of patients, cultivating novel and different collaborations, and applying humility to humanize technology are three facets underlying this approach. Human-centered design can help expand our perspective to serve as another essential tool to help further refine diabetes technology.

Indexed as

Diabetes MellitusDiabetes Mellitus, Type 1Blood GlucoseBlood Glucose Self-MonitoringHumansQuality of LifeTechnologyBlood Glucosecontinuous glucose monitoringdiabetes mellitusdiabetes technologyhuman-centered designhumanizing technologypatient engagement

Identifiers

PMID37970832
PMCPMC10899855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.